Progression-free survival as a surrogate for overall survival in advanced cancer.

被引：0
|
作者：
Gillies, Eric
Holdai, Veera
Cowall, David Eric
机构：
[1] Salisbury Univ, Salisbury, MD USA
[2] Coastal Hosp Inc, Salisbury, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e17765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e17765
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Predicting Overall Survival and Progression-Free Survival Using Tumor Dynamics in Advanced Breast Cancer Patients
    Lim, Hyeong-Seok
    Sun, Wan
    Parivar, Kourosh
    Wang, Diane
    [J]. AAPS JOURNAL, 2019, 21 (02):
  • [42] PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Dimopoulos, M.
    Sonneveld, P.
    Nahi, H.
    Kumar, S.
    Hashim, M.
    Kulakova, M.
    Duran, M.
    Heeg, B.
    Lam, A.
    Dearden, L.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A408 - A408
  • [43] Progression-free survival is a robust surrogate endpoint of overall survival in immunotherapy trials of hepatocellular carcinoma
    Celsa, C.
    Cabibbo, G.
    Enea, M.
    Battaglia, S.
    Rizzo, G. E. M.
    Busacca, A.
    Matranga, D.
    Attanasio, M.
    Reig, M.
    Craxi, A.
    Camma, C.
    [J]. DIGESTIVE AND LIVER DISEASE, 2021, 53 : S35 - S35
  • [44] Progression-free survival as a surrogate endpoint for overall survival in patients with third-line or later-line chemotherapy for advanced gastric cancer
    Liu, Liya
    Yu, Hao
    Huang, Lihong
    Shao, Fang
    Bai, Jianling
    Lou, Donghua
    Chen, Feng
    [J]. OncoTargets and Therapy, 2015, 8 : 921 - 928
  • [45] Progression-free survival and time to progression as surrogate markers of overall survival in patients with advanced gastric cancer: Literature-based analysis of 36 randomized trials
    Shitara, K.
    Ikeda, J.
    Mizota, A.
    Kondo, C.
    Nomura, M.
    Yokota, T.
    Takahari, D.
    Ura, T.
    Muro, K.
    Matsuo, K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [46] Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
    Hirai, Takehiro
    Nemoto, Asuka
    Ito, Yoshinori
    Matsuura, Masaaki
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2020, 181 (01) : 189 - 198
  • [47] META-ANALYSIS OF THE VALIDITY OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL IN METASTATIC COLORECTAL CANCER TRIALS
    Chirila, C.
    Odom, D. M.
    Devercelli, G.
    Khan, S.
    Sherif, B. N.
    Kaye, J. A.
    Molnar, I.
    Sherrill, B. H.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 202 - 202
  • [48] Progression-free survival as a surrogate for overall survival in trials of immune checkpoint inhibitors in pan cancer evaluated by RECIST 1.1
    Lin, L.
    Xu, H.
    Ding, J.
    Qin, T.
    Xu, M.
    Shen, J.
    Jiang, W.
    Wang, J.
    Cheng, D.
    Li, Z.
    Hu, H.
    Yu, Y.
    Yao, H.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S1430 - S1430
  • [49] Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
    Takehiro Hirai
    Asuka Nemoto
    Yoshinori Ito
    Masaaki Matsuura
    [J]. Breast Cancer Research and Treatment, 2020, 181 : 189 - 198
  • [50] Authors’ Reply to Schoenfeld: “Progression-Free Survival as a Surrogate for Overall Survival in Clinical Trials of Targeted Therapy in Advanced Solid Tumors”
    Stefan Michiels
    Everardo D. Saad
    Marc Buyse
    [J]. Drugs, 2017, 77 : 1139 - 1140
12345